Medtronic
MDT
NZ$145.73
Share price
0.12%
Change (1 day)
15.17%
Change (1 year)
Categories
Medtronic plc, headquartered in Dublin, is a listed company in the field of medical technology. The company is known for its pacemakers, implantable cardioverter defibrillators, heart valves, insulin pumps, aortic stent grafts, coronary stents and neurostimulators. Medtronic manufactures more than half of all pacemakers implanted worldwide.
Medtronic (MDT) - Total debt
Total debt on the balance sheet as of January 2025 : NZ$43.86 Billion
According to Medtronic's latest financial reports the company's total debt is NZ$43.86 Billion. A company’s total debt is the sum of all current and non-current debts.
Medtronic - Total debt on balance sheet (from 1996 to 2025)
Total debt by year
| Year | Total debt | Change |
|---|---|---|
| 2024-04-30 | NZ$42.56 B | 7.82% |
| 2023-04-30 | NZ$39.47 B | 5.82% |
| 2022-04-30 | NZ$37.30 B | 1.34% |
| 2021-04-30 | NZ$36.81 B | -9.15% |
| 2020-04-30 | NZ$40.51 B | 6.53% |
| 2019-04-30 | NZ$38.03 B | 3.9% |
| 2018-04-30 | NZ$36.60 B | -24.66% |
| 2017-04-30 | NZ$48.59 B | 9.22% |
| 2016-04-30 | NZ$44.48 B | -6.3% |
| 2015-04-30 | NZ$47.47 B | 244.33% |
| 2014-04-30 | NZ$13.78 B | 11.41% |
| 2013-04-30 | NZ$12.37 B | -3.24% |
| 2012-04-30 | NZ$12.78 B | 7.06% |
| 2011-04-30 | NZ$11.94 B | -9.14% |
| 2010-04-30 | NZ$13.14 B | 10.89% |
| 2009-04-30 | NZ$11.85 B | 32.19% |
| 2008-04-30 | NZ$8.96 B | 9.07% |
| 2007-04-30 | NZ$8.22 B | -33.69% |
| 2006-04-30 | NZ$12.40 B | 270.44% |
| 2005-04-30 | NZ$3.34 B | -10.42% |
| 2004-04-30 | NZ$3.73 B | -11.6% |
| 2003-04-30 | NZ$4.22 B | -25.01% |
| 2002-04-30 | NZ$5.63 B | 1360.12% |
| 2001-04-30 | NZ$0.38 B | -43.78% |
| 2000-04-30 | NZ$0.68 B | 46.38% |
| 1999-04-30 | NZ$0.46 B | 35.73% |
| 1998-04-30 | NZ$0.34 B | 98.94% |
| 1997-04-30 | NZ$0.17 B | 57.44% |
| 1996-04-30 | NZ$0.11 B |
Total debt for similar companies or competitors
| Company | Total debt/th> | differencediff. | Country |
|---|---|---|---|
 Boston Scientific BSX | NZ$19.30 B | -56.00% | 🇺🇸 USA |
 Stryker Corporation SYK | NZ$27.66 B | -36.93% | 🇺🇸 USA |
 Edwards Lifesciences EW | NZ$1.15 B | -97.37% | 🇺🇸 USA |
 Johnson & Johnson JNJ | NZ$86.14 B | 96.38% | 🇺🇸 USA |
 Abbott Laboratories ABT | NZ$21.83 B | -50.23% | 🇺🇸 USA |
 CONMED CNMD | NZ$1.47 B | -96.65% | 🇺🇸 USA |
 Baxter BAX | NZ$16.99 B | -61.25% | 🇺🇸 USA |
 Owens & Minor
OMI | NZ$3.74 B | -91.46% | 🇺🇸 USA |
 Integra LifeSciences IART | NZ$3.32 B | -92.41% | 🇺🇸 USA |